Clinical Practice Guidelines for Hepatocellular Carcinoma: The Japan Society of Hepatology 2021 version (5th JSH‐HCC Guidelines)

The fifth version of the Clinical Practice Guidelines for Hepatocellular Carcinoma was revised by the Japan Society of Hepatology, according to the methodology of evidence‐based medicine and partly to the Grading of Recommendations Assessment, Development and Evaluation system, which was published i...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Hepatology research Jg. 53; H. 5; S. 383 - 390
Hauptverfasser: Hasegawa, Kiyoshi, Takemura, Nobuyuki, Yamashita, Tatsuya, Watadani, Takeyuki, Kaibori, Masaki, Kubo, Shoji, Shimada, Mitsuo, Nagano, Hiroaki, Hatano, Etsuro, Aikata, Hiroshi, Iijima, Hiroko, Ueshima, Kazuomi, Ohkawa, Kazuyoshi, Genda, Takuya, Tsuchiya, Kaoru, Torimura, Takuji, Ikeda, Masafumi, Furuse, Junji, Akahane, Masaaki, Kobayashi, Satoshi, Sakurai, Hideyuki, Takeda, Atsuya, Murakami, Takamichi, Motosugi, Utaroh, Matsuyama, Yutaka, Kudo, Masatoshi, Tateishi, Ryosuke
Format: Journal Article
Sprache:Englisch
Veröffentlicht: Netherlands Wiley Subscription Services, Inc 01.05.2023
Schlagworte:
algorithm for surveillance and diagnosis
algorithm for systemic therapy
algorithm for treatment
Algorithms
Clinical practice guidelines
Hepatocellular carcinoma
clinical practice guidelines
algorithm for systemic therapy
algorithm for treatment
algorithm for surveillance and diagnosis
hepatocellular carcinoma
ISSN:1386-6346, 1872-034X
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The fifth version of the Clinical Practice Guidelines for Hepatocellular Carcinoma was revised by the Japan Society of Hepatology, according to the methodology of evidence‐based medicine and partly to the Grading of Recommendations Assessment, Development and Evaluation system, which was published in October 2021 in Japanese. In addition to surveillance–diagnostic and treatment algorithms, a new algorithm for systemic therapy has been created, as multiple drugs for hepatocellular carcinoma can be currently selected. Here, new or revised algorithms and evidence on which the recommendations are based are described.
Bibliographie:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ISSN:1386-6346
1872-034X
DOI:10.1111/hepr.13892